glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 Potential kidney protective effects of
Description
FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities
A GLP-1 analog, ROSE-010, was tested in IBS patients for pain relief, effectively increasing intestinal muscle movement [111]
References InfantRisk Center
GIP and GLP-1 bind to their respective receptors: the GIP receptor (GIPR) and GLP-1R to mediate their pleiotropic cellular effects [10]
doi: 10.1146/annurev.ph.34.030172.000305
